Structure

Physi-Chem Properties

Molecular Weight:  676.37
Volume:  687.668
LogP:  2.678
LogD:  2.757
LogS:  -3.139
# Rotatable Bonds:  9
TPSA:  200.67
# H-Bond Aceptor:  14
# H-Bond Donor:  5
# Rings:  2
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.229
Synthetic Accessibility Score:  5.243
Fsp3:  0.647
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.702
MDCK Permeability:  0.00012121887266403064
Pgp-inhibitor:  0.999
Pgp-substrate:  0.972
Human Intestinal Absorption (HIA):  0.018
20% Bioavailability (F20%):  0.013
30% Bioavailability (F30%):  0.966

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.059
Plasma Protein Binding (PPB):  67.14556884765625%
Volume Distribution (VD):  0.42
Pgp-substrate:  19.13686752319336%

ADMET: Metabolism

CYP1A2-inhibitor:  0.006
CYP1A2-substrate:  0.014
CYP2C19-inhibitor:  0.056
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.094
CYP2C9-substrate:  0.087
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.082
CYP3A4-inhibitor:  0.714
CYP3A4-substrate:  0.228

ADMET: Excretion

Clearance (CL):  5.034
Half-life (T1/2):  0.407

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.97
Drug-inuced Liver Injury (DILI):  0.877
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.403
Maximum Recommended Daily Dose:  0.073
Skin Sensitization:  0.049
Carcinogencity:  0.064
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.029

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC268841

Natural Product ID:  NPC268841
Common Name*:   Hirsutatin A
IUPAC Name:   (3S,6S,9S,12S,15S,18S)-15-benzyl-9-[(1R)-1-hydroxyethyl]-6-(hydroxymethyl)-13-methyl-12,18-bis(2-methylpropyl)-3-propan-2-yl-1,4-dioxa-7,10,13,16-tetrazacyclooctadecane-2,5,8,11,14,17-hexone
Synonyms:  
Standard InCHIKey:  IKUBGKAJYBJGOR-CVSBKWFLSA-N
Standard InCHI:  InChI=1S/C34H52N4O10/c1-18(2)14-25-29(41)37-27(21(7)40)31(43)36-24(17-39)33(45)48-28(20(5)6)34(46)47-26(15-19(3)4)30(42)35-23(32(44)38(25)8)16-22-12-10-9-11-13-22/h9-13,18-21,23-28,39-40H,14-17H2,1-8H3,(H,35,42)(H,36,43)(H,37,41)/t21-,23+,24+,25+,26+,27+,28+/m1/s1
SMILES:  OC[C@@H]1N=C(O)[C@@H](N=C(O)[C@H](CC(C)C)N(C)C(=O)[C@@H](N=C([C@@H](OC(=O)[C@@H](OC1=O)C(C)C)CC(C)C)O)Cc1ccccc1)[C@H](O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL454263
PubChem CID:   11707361
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0001813] Peptidomimetics
        • [CHEMONTID:0001961] Depsipeptides
          • [CHEMONTID:0001994] Cyclic depsipeptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32771 hirsutella nivea bcc 2594 Species Ophiocordycipitaceae Eukaryota n.a. n.a. n.a. PMID[16309324]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC = 50.0 ug.mL-1 PMID[524206]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC268841 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC46098
1.0 High Similarity NPC307357
0.9248 High Similarity NPC68865
0.8986 High Similarity NPC201244
0.8986 High Similarity NPC477217
0.8929 High Similarity NPC471820
0.8929 High Similarity NPC471821
0.8873 High Similarity NPC162104
0.8857 High Similarity NPC135121
0.8857 High Similarity NPC145113
0.8759 High Similarity NPC476133
0.8759 High Similarity NPC470884
0.8759 High Similarity NPC92784
0.8759 High Similarity NPC98424
0.8759 High Similarity NPC178662
0.8714 High Similarity NPC5620
0.8705 High Similarity NPC176226
0.8705 High Similarity NPC139326
0.8699 High Similarity NPC197743
0.8699 High Similarity NPC297145
0.8686 High Similarity NPC127741
0.8643 High Similarity NPC52748
0.8633 High Similarity NPC269398
0.8633 High Similarity NPC263493
0.8571 High Similarity NPC197682
0.8561 High Similarity NPC476259
0.8551 High Similarity NPC471265
0.8551 High Similarity NPC471264
0.8521 High Similarity NPC262077
0.8511 High Similarity NPC476978
0.85 High Similarity NPC168113
0.8472 Intermediate Similarity NPC2501
0.8472 Intermediate Similarity NPC129666
0.8462 Intermediate Similarity NPC225648
0.8462 Intermediate Similarity NPC329761
0.8451 Intermediate Similarity NPC209509
0.8431 Intermediate Similarity NPC196091
0.8429 Intermediate Similarity NPC239762
0.8429 Intermediate Similarity NPC163392
0.8403 Intermediate Similarity NPC105717
0.837 Intermediate Similarity NPC319766
0.831 Intermediate Similarity NPC161069
0.8299 Intermediate Similarity NPC122590
0.8276 Intermediate Similarity NPC240848
0.8273 Intermediate Similarity NPC248283
0.8244 Intermediate Similarity NPC237420
0.8239 Intermediate Similarity NPC469427
0.8239 Intermediate Similarity NPC469426
0.8176 Intermediate Similarity NPC286551
0.8168 Intermediate Similarity NPC169328
0.8106 Intermediate Similarity NPC310467
0.8105 Intermediate Similarity NPC471052
0.8105 Intermediate Similarity NPC471051
0.8105 Intermediate Similarity NPC471053
0.8082 Intermediate Similarity NPC138775
0.8014 Intermediate Similarity NPC314358
0.7985 Intermediate Similarity NPC478015
0.7985 Intermediate Similarity NPC45777
0.7985 Intermediate Similarity NPC478014
0.7985 Intermediate Similarity NPC200964
0.7985 Intermediate Similarity NPC478016
0.7985 Intermediate Similarity NPC477061
0.7974 Intermediate Similarity NPC471527
0.7971 Intermediate Similarity NPC89923
0.7971 Intermediate Similarity NPC239990
0.7971 Intermediate Similarity NPC152850
0.7971 Intermediate Similarity NPC71933
0.7971 Intermediate Similarity NPC105114
0.7945 Intermediate Similarity NPC313867
0.7945 Intermediate Similarity NPC316008
0.7943 Intermediate Similarity NPC287401
0.7941 Intermediate Similarity NPC46427
0.7941 Intermediate Similarity NPC6975
0.7908 Intermediate Similarity NPC62104
0.7908 Intermediate Similarity NPC1390
0.7899 Intermediate Similarity NPC136453
0.7877 Intermediate Similarity NPC315283
0.7877 Intermediate Similarity NPC314388
0.7872 Intermediate Similarity NPC246079
0.7868 Intermediate Similarity NPC252878
0.7836 Intermediate Similarity NPC470546
0.7823 Intermediate Similarity NPC315266
0.7815 Intermediate Similarity NPC473341
0.7801 Intermediate Similarity NPC130309
0.7801 Intermediate Similarity NPC157311
0.78 Intermediate Similarity NPC475168
0.78 Intermediate Similarity NPC7817
0.7794 Intermediate Similarity NPC202521
0.7778 Intermediate Similarity NPC43755
0.7761 Intermediate Similarity NPC470545
0.7746 Intermediate Similarity NPC8761
0.7746 Intermediate Similarity NPC44805
0.7721 Intermediate Similarity NPC476990
0.7707 Intermediate Similarity NPC5719
0.7707 Intermediate Similarity NPC217804
0.7707 Intermediate Similarity NPC22883
0.7707 Intermediate Similarity NPC210377
0.7702 Intermediate Similarity NPC26108
0.7698 Intermediate Similarity NPC101719
0.7687 Intermediate Similarity NPC239357
0.7687 Intermediate Similarity NPC470544
0.7669 Intermediate Similarity NPC475421
0.7647 Intermediate Similarity NPC470902
0.7626 Intermediate Similarity NPC222466
0.7616 Intermediate Similarity NPC283783
0.761 Intermediate Similarity NPC63040
0.7603 Intermediate Similarity NPC132636
0.7593 Intermediate Similarity NPC477462
0.7593 Intermediate Similarity NPC318930
0.7593 Intermediate Similarity NPC317362
0.7591 Intermediate Similarity NPC80150
0.7591 Intermediate Similarity NPC190663
0.7571 Intermediate Similarity NPC47667
0.7554 Intermediate Similarity NPC175726
0.7554 Intermediate Similarity NPC474082
0.7552 Intermediate Similarity NPC255447
0.7547 Intermediate Similarity NPC15068
0.7535 Intermediate Similarity NPC473322
0.753 Intermediate Similarity NPC167763
0.753 Intermediate Similarity NPC470903
0.753 Intermediate Similarity NPC470112
0.7519 Intermediate Similarity NPC273814
0.7516 Intermediate Similarity NPC471568
0.7516 Intermediate Similarity NPC473693
0.75 Intermediate Similarity NPC473502
0.7485 Intermediate Similarity NPC473354
0.7483 Intermediate Similarity NPC200589
0.7482 Intermediate Similarity NPC160493
0.7468 Intermediate Similarity NPC73655
0.7463 Intermediate Similarity NPC35850
0.7463 Intermediate Similarity NPC276949
0.7445 Intermediate Similarity NPC314992
0.744 Intermediate Similarity NPC299806
0.7429 Intermediate Similarity NPC35996
0.7423 Intermediate Similarity NPC273755
0.7423 Intermediate Similarity NPC248670
0.7417 Intermediate Similarity NPC81026
0.7413 Intermediate Similarity NPC111428
0.7407 Intermediate Similarity NPC33742
0.7391 Intermediate Similarity NPC209463
0.7381 Intermediate Similarity NPC471049
0.7381 Intermediate Similarity NPC471048
0.7381 Intermediate Similarity NPC471050
0.7378 Intermediate Similarity NPC326407
0.7378 Intermediate Similarity NPC317725
0.7378 Intermediate Similarity NPC471165
0.7376 Intermediate Similarity NPC476241
0.7376 Intermediate Similarity NPC476260
0.7375 Intermediate Similarity NPC63931
0.7351 Intermediate Similarity NPC266741
0.7351 Intermediate Similarity NPC322878
0.7346 Intermediate Similarity NPC186617
0.7337 Intermediate Similarity NPC315542
0.7333 Intermediate Similarity NPC77905
0.7333 Intermediate Similarity NPC50016
0.7324 Intermediate Similarity NPC476125
0.7324 Intermediate Similarity NPC476179
0.7317 Intermediate Similarity NPC306804
0.7317 Intermediate Similarity NPC137627
0.7299 Intermediate Similarity NPC285926
0.7299 Intermediate Similarity NPC2265
0.7299 Intermediate Similarity NPC14672
0.7299 Intermediate Similarity NPC315276
0.7297 Intermediate Similarity NPC6570
0.7296 Intermediate Similarity NPC469901
0.7292 Intermediate Similarity NPC213969
0.7292 Intermediate Similarity NPC165726
0.7286 Intermediate Similarity NPC71684
0.7284 Intermediate Similarity NPC294516
0.7284 Intermediate Similarity NPC107938
0.7279 Intermediate Similarity NPC141050
0.7278 Intermediate Similarity NPC294951
0.7273 Intermediate Similarity NPC159767
0.7273 Intermediate Similarity NPC279871
0.7273 Intermediate Similarity NPC155506
0.7267 Intermediate Similarity NPC472923
0.7262 Intermediate Similarity NPC476321
0.7259 Intermediate Similarity NPC474584
0.7256 Intermediate Similarity NPC89831
0.7254 Intermediate Similarity NPC22746
0.7246 Intermediate Similarity NPC45037
0.7241 Intermediate Similarity NPC300315
0.7219 Intermediate Similarity NPC471526
0.7214 Intermediate Similarity NPC476183
0.7197 Intermediate Similarity NPC39431
0.7195 Intermediate Similarity NPC475204
0.7195 Intermediate Similarity NPC40234
0.7195 Intermediate Similarity NPC46009
0.7195 Intermediate Similarity NPC475123
0.7172 Intermediate Similarity NPC469666
0.7169 Intermediate Similarity NPC158277
0.7169 Intermediate Similarity NPC476227
0.7163 Intermediate Similarity NPC476281
0.7163 Intermediate Similarity NPC476184
0.7152 Intermediate Similarity NPC230611
0.7143 Intermediate Similarity NPC194671
0.7143 Intermediate Similarity NPC269750
0.7069 Intermediate Similarity NPC163961
0.7069 Intermediate Similarity NPC473305
0.7066 Intermediate Similarity NPC473402

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC268841 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8286 Intermediate Similarity NPD8173 Phase 2
0.8286 Intermediate Similarity NPD8172 Phase 2
0.8214 Intermediate Similarity NPD7113 Clinical (unspecified phase)
0.8074 Intermediate Similarity NPD2584 Suspended
0.7914 Intermediate Similarity NPD3626 Phase 3
0.7895 Intermediate Similarity NPD8417 Discontinued
0.7838 Intermediate Similarity NPD8323 Discontinued
0.7727 Intermediate Similarity NPD7749 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD8416 Discontinued
0.7552 Intermediate Similarity NPD4738 Phase 2
0.7517 Intermediate Similarity NPD8265 Approved
0.7483 Intermediate Similarity NPD6852 Discontinued
0.7445 Intermediate Similarity NPD2218 Phase 2
0.7445 Intermediate Similarity NPD2217 Approved
0.7386 Intermediate Similarity NPD6088 Approved
0.7365 Intermediate Similarity NPD6901 Phase 3
0.7343 Intermediate Similarity NPD3604 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD3608 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD5339 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD4177 Approved
0.7292 Intermediate Similarity NPD4175 Approved
0.7241 Intermediate Similarity NPD4125 Approved
0.723 Intermediate Similarity NPD8643 Discontinued
0.7219 Intermediate Similarity NPD4152 Approved
0.7219 Intermediate Similarity NPD8076 Discontinued
0.7192 Intermediate Similarity NPD6919 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD6073 Approved
0.7181 Intermediate Similarity NPD5725 Approved
0.7171 Intermediate Similarity NPD6119 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD6623 Phase 3
0.7153 Intermediate Similarity NPD2585 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD5747 Discontinued
0.707 Intermediate Similarity NPD7613 Discontinued
0.7067 Intermediate Similarity NPD4782 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD4791 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD4153 Approved
0.702 Intermediate Similarity NPD6294 Approved
0.702 Intermediate Similarity NPD6295 Approved
0.7014 Intermediate Similarity NPD4677 Discontinued
0.7013 Intermediate Similarity NPD6860 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD7979 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD2613 Approved
0.6993 Remote Similarity NPD2608 Approved
0.6993 Remote Similarity NPD2612 Approved
0.6993 Remote Similarity NPD3131 Approved
0.6993 Remote Similarity NPD4218 Approved
0.6993 Remote Similarity NPD2610 Approved
0.6993 Remote Similarity NPD3132 Approved
0.6993 Remote Similarity NPD2609 Approved
0.6993 Remote Similarity NPD4215 Approved
0.6993 Remote Similarity NPD2611 Approved
0.6993 Remote Similarity NPD4216 Approved
0.6993 Remote Similarity NPD4217 Approved
0.698 Remote Similarity NPD3087 Approved
0.698 Remote Similarity NPD3615 Approved
0.698 Remote Similarity NPD7634 Clinical (unspecified phase)
0.698 Remote Similarity NPD3088 Approved
0.698 Remote Similarity NPD2573 Approved
0.698 Remote Similarity NPD2574 Discontinued
0.698 Remote Similarity NPD2570 Approved
0.698 Remote Similarity NPD2566 Approved
0.698 Remote Similarity NPD2571 Approved
0.698 Remote Similarity NPD3090 Approved
0.698 Remote Similarity NPD4745 Approved
0.698 Remote Similarity NPD3616 Approved
0.698 Remote Similarity NPD2572 Clinical (unspecified phase)
0.698 Remote Similarity NPD4746 Phase 3
0.698 Remote Similarity NPD3089 Approved
0.698 Remote Similarity NPD3614 Approved
0.6978 Remote Similarity NPD1348 Approved
0.6975 Remote Similarity NPD4557 Approved
0.6974 Remote Similarity NPD5301 Clinical (unspecified phase)
0.6968 Remote Similarity NPD2575 Approved
0.6959 Remote Similarity NPD4794 Discontinued
0.6948 Remote Similarity NPD2436 Approved
0.6948 Remote Similarity NPD2437 Approved
0.6948 Remote Similarity NPD6681 Discovery
0.6944 Remote Similarity NPD3072 Approved
0.6944 Remote Similarity NPD3073 Approved
0.6944 Remote Similarity NPD3071 Approved
0.6943 Remote Similarity NPD6631 Clinical (unspecified phase)
0.6933 Remote Similarity NPD5296 Approved
0.6918 Remote Similarity NPD2160 Approved
0.6918 Remote Similarity NPD2625 Approved
0.6918 Remote Similarity NPD2628 Approved
0.6918 Remote Similarity NPD2626 Approved
0.6918 Remote Similarity NPD2159 Approved
0.6918 Remote Similarity NPD2627 Approved
0.6905 Remote Similarity NPD7965 Phase 2
0.6905 Remote Similarity NPD7964 Clinical (unspecified phase)
0.6901 Remote Similarity NPD4504 Clinical (unspecified phase)
0.6899 Remote Similarity NPD4185 Clinical (unspecified phase)
0.6894 Remote Similarity NPD7267 Clinical (unspecified phase)
0.6892 Remote Similarity NPD5202 Clinical (unspecified phase)
0.6887 Remote Similarity NPD4686 Approved
0.6887 Remote Similarity NPD4685 Phase 3
0.6887 Remote Similarity NPD4684 Phase 3
0.6875 Remote Similarity NPD4761 Approved
0.6875 Remote Similarity NPD4706 Clinical (unspecified phase)
0.6875 Remote Similarity NPD4806 Approved
0.6875 Remote Similarity NPD4807 Approved
0.6875 Remote Similarity NPD4762 Approved
0.6867 Remote Similarity NPD3561 Clinical (unspecified phase)
0.6861 Remote Similarity NPD3642 Approved
0.6861 Remote Similarity NPD3643 Approved
0.6861 Remote Similarity NPD3644 Approved
0.6859 Remote Similarity NPD6676 Phase 2
0.6852 Remote Similarity NPD7118 Clinical (unspecified phase)
0.6849 Remote Similarity NPD6792 Phase 3
0.6849 Remote Similarity NPD5367 Discontinued
0.6839 Remote Similarity NPD5341 Clinical (unspecified phase)
0.6835 Remote Similarity NPD2650 Approved
0.6835 Remote Similarity NPD2652 Approved
0.6824 Remote Similarity NPD3664 Approved
0.6824 Remote Similarity NPD3661 Approved
0.6824 Remote Similarity NPD3663 Approved
0.6824 Remote Similarity NPD3662 Phase 3
0.6818 Remote Similarity NPD4172 Approved
0.6818 Remote Similarity NPD4173 Approved
0.6815 Remote Similarity NPD7130 Phase 3
0.6809 Remote Similarity NPD5292 Approved
0.6809 Remote Similarity NPD5291 Approved
0.68 Remote Similarity NPD3632 Clinical (unspecified phase)
0.68 Remote Similarity NPD4619 Approved
0.68 Remote Similarity NPD4621 Approved
0.6792 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6786 Remote Similarity NPD7608 Discontinued
0.6783 Remote Similarity NPD5981 Approved
0.6779 Remote Similarity NPD5203 Approved
0.6779 Remote Similarity NPD4620 Approved
0.6779 Remote Similarity NPD5263 Approved
0.6779 Remote Similarity NPD5201 Approved
0.6779 Remote Similarity NPD4617 Approved
0.6779 Remote Similarity NPD4676 Approved
0.6774 Remote Similarity NPD7720 Phase 2
0.677 Remote Similarity NPD8315 Phase 1
0.6768 Remote Similarity NPD7599 Phase 2
0.6765 Remote Similarity NPD5979 Clinical (unspecified phase)
0.6757 Remote Similarity NPD3588 Discontinued
0.6753 Remote Similarity NPD7728 Clinical (unspecified phase)
0.6752 Remote Similarity NPD5298 Clinical (unspecified phase)
0.6736 Remote Similarity NPD7342 Discontinued
0.6736 Remote Similarity NPD4488 Clinical (unspecified phase)
0.6735 Remote Similarity NPD3125 Approved
0.673 Remote Similarity NPD7892 Clinical (unspecified phase)
0.6727 Remote Similarity NPD7600 Phase 2
0.6711 Remote Similarity NPD5204 Approved
0.6711 Remote Similarity NPD5121 Approved
0.6711 Remote Similarity NPD3040 Approved
0.6711 Remote Similarity NPD5120 Approved
0.6711 Remote Similarity NPD5119 Approved
0.6709 Remote Similarity NPD6552 Clinical (unspecified phase)
0.6708 Remote Similarity NPD7131 Phase 3
0.669 Remote Similarity NPD4106 Approved
0.669 Remote Similarity NPD4135 Approved
0.669 Remote Similarity NPD4136 Approved
0.6689 Remote Similarity NPD5581 Approved
0.6688 Remote Similarity NPD5264 Approved
0.6688 Remote Similarity NPD5265 Approved
0.6686 Remote Similarity NPD5681 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4646 Approved
0.6667 Remote Similarity NPD4647 Approved
0.6667 Remote Similarity NPD4648 Approved
0.6667 Remote Similarity NPD7978 Discontinued
0.6667 Remote Similarity NPD7972 Discontinued
0.6667 Remote Similarity NPD2022 Approved
0.6646 Remote Similarity NPD6078 Clinical (unspecified phase)
0.6645 Remote Similarity NPD3480 Approved
0.6643 Remote Similarity NPD7522 Discontinued
0.6627 Remote Similarity NPD7080 Clinical (unspecified phase)
0.6623 Remote Similarity NPD2051 Approved
0.6623 Remote Similarity NPD2045 Approved
0.6623 Remote Similarity NPD2047 Approved
0.6623 Remote Similarity NPD2044 Approved
0.6623 Remote Similarity NPD2048 Approved
0.6623 Remote Similarity NPD2046 Approved
0.6623 Remote Similarity NPD2043 Approved
0.6623 Remote Similarity NPD2049 Clinical (unspecified phase)
0.6623 Remote Similarity NPD2050 Clinical (unspecified phase)
0.6623 Remote Similarity NPD21 Approved
0.6622 Remote Similarity NPD2634 Clinical (unspecified phase)
0.6608 Remote Similarity NPD8126 Clinical (unspecified phase)
0.6608 Remote Similarity NPD8124 Phase 3
0.6603 Remote Similarity NPD7511 Approved
0.6603 Remote Similarity NPD7512 Approved
0.6601 Remote Similarity NPD5323 Approved
0.66 Remote Similarity NPD7828 Discontinued
0.6599 Remote Similarity NPD5108 Clinical (unspecified phase)
0.6597 Remote Similarity NPD6343 Approved
0.6597 Remote Similarity NPD6345 Approved
0.6579 Remote Similarity NPD2078 Clinical (unspecified phase)
0.6573 Remote Similarity NPD4574 Approved
0.6573 Remote Similarity NPD3123 Discovery
0.6573 Remote Similarity NPD4576 Approved
0.6568 Remote Similarity NPD4508 Discontinued
0.6561 Remote Similarity NPD2087 Approved
0.6561 Remote Similarity NPD2088 Approved
0.6558 Remote Similarity NPD3908 Approved
0.6552 Remote Similarity NPD4102 Approved
0.6552 Remote Similarity NPD4105 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data